Addition of high-risk HPV testing improves the current guidelines on follow-up after treatment for cervical intraepithelial neoplasia

We assessed a possible role for high-risk human papillomavirus (HPV) testing in the policy after treatment for cervical intraepithelial neoplasia (CIN) 2 or 3 (moderate to severe dysplasia). According to the Dutch guidelines follow-up after treatment consists of cervical cytology at 6, 12 and 24 mon...

Descripción completa

Detalles Bibliográficos
Autores principales: Nobbenhuis, M A E, Meijer, C J L M, Brule, A J C van den, Rozendaal, L, Voorhorst, F J, Risse, E K J, Verheijen, R H M, Helmerhorst, T J M
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2001
Materias:
Regular Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363818/
https://www.ncbi.nlm.nih.gov/pubmed/11259094
http://dx.doi.org/10.1054/bjoc.2000.1689

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363818/
https://www.ncbi.nlm.nih.gov/pubmed/11259094
http://dx.doi.org/10.1054/bjoc.2000.1689

Ejemplares similares